IGF2BP2 and head and neck squamous cell carcinoma: The data showed increased expression of IGF2BP2 in HNSCC, which in turn promoted tumor cell proliferation through the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)-protein kinase B (Akt) pathway.